Allogenic cytokine induced memory like natural killer cell therapy(ImmunityBio)

N/A

Report date: 2023/03/15 10:34:35

Base Information

Drug NameAllogenic cytokine induced memory like natural killer cell therapy(ImmunityBio)

Drug Alias NameAllogenic cytokine induced memory like NK cell therapy(ImmunityBio)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell

Mechanisms of ActionNatural killer cell replacementsCytokine-induced killer cells replacements

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunitybio Inc

China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A